$3.79 Billion is the total value of NEA Management Company, LLC's 57 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DM | New | DESKTOP METAL INC | $488,757,000 | – | 28,416,088 | +100.0% | 12.90% | – |
| ALLK | Sell | ALLAKOS INC | $303,059,000 | +64.0% | 2,164,704 | -4.6% | 8.00% | +2.3% |
| EAR | New | EARGO INC | $292,269,000 | – | 6,520,948 | +100.0% | 7.72% | – |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $243,445,000 | +83.1% | 1,590,002 | 0.0% | 6.43% | +14.2% | |
| NET | CLOUDFLARE INC | $211,971,000 | +1768.1% | 2,763,583 | 0.0% | 5.60% | +1066.0% | |
| NKTX | NKARTA INC | $178,569,000 | +104.5% | 2,904,974 | 0.0% | 4.72% | +27.5% | |
| OPEN | New | OPENDOOR TECHNOLOGIES INC | $151,531,000 | – | 6,666,548 | +100.0% | 4.00% | – |
| RYTM | RHYTHM PHARMACEUTICALS INC | $142,948,000 | +34.3% | 4,912,306 | 0.0% | 3.77% | -16.3% | |
| SPT | Sell | SPROUT SOCIAL INC | $140,321,000 | -34.9% | 3,090,080 | -44.8% | 3.70% | -59.4% |
| OYST | OYSTER PT PHARMA INC | $111,514,000 | -10.8% | 5,925,287 | 0.0% | 2.94% | -44.4% | |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $110,568,000 | +6.0% | 3,449,845 | 0.0% | 2.92% | -33.9% | |
| PANW | New | PALO ALTO NETWORKS INC | $95,488,000 | – | 268,684 | +100.0% | 2.52% | – |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCadr | $92,075,000 | -32.5% | 17,082,611 | 0.0% | 2.43% | -57.9% | |
| IMRA | IMARA INC | $88,579,000 | +8.4% | 4,017,170 | 0.0% | 2.34% | -32.4% | |
| ARDX | ARDELYX INC | $88,209,000 | +23.2% | 13,633,582 | 0.0% | 2.33% | -23.2% | |
| AKUS | AKOUOS INC | $85,239,000 | -13.3% | 4,298,488 | 0.0% | 2.25% | -45.9% | |
| TRILLIUM THERAPEUTICS INC | $84,382,000 | +3.5% | 5,736,363 | 0.0% | 2.23% | -35.4% | ||
| MIRM | MIRUM PHARMACEUTICALS INC | $73,119,000 | -9.4% | 4,187,801 | 0.0% | 1.93% | -43.5% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $71,538,000 | -6.1% | 5,172,683 | 0.0% | 1.89% | -41.4% | |
| ANNX | ANNEXON INC | $62,516,000 | -17.2% | 2,497,661 | 0.0% | 1.65% | -48.4% | |
| INZY | INOZYME PHARMA INC | $50,452,000 | -21.5% | 2,444,379 | 0.0% | 1.33% | -51.0% | |
| GRTX | GALERA THERAPEUTICS INC | $44,633,000 | +13.2% | 4,362,986 | 0.0% | 1.18% | -29.5% | |
| CSPR | CASPER SLEEP INC | $38,291,000 | -14.5% | 6,226,130 | 0.0% | 1.01% | -46.6% | |
| BE | BLOOM ENERGY CORP | $38,213,000 | +59.5% | 1,333,333 | 0.0% | 1.01% | -0.6% | |
| VRNA | VERONA PHARMA PLCads | $35,760,000 | +12.2% | 5,108,563 | 0.0% | 0.94% | -30.1% | |
| AFMD | AFFIMED NV | $35,656,000 | +71.7% | 6,126,488 | 0.0% | 0.94% | +7.1% | |
| GLYC | GLYCOMIMETICS INC | $34,175,000 | +22.5% | 9,089,041 | 0.0% | 0.90% | -23.6% | |
| GNCA | GENOCEA BIOSCIENCES INC | $25,112,000 | +5.7% | 10,376,936 | 0.0% | 0.66% | -34.1% | |
| MTCR | METACRINE INC | $24,075,000 | -23.0% | 3,062,977 | 0.0% | 0.64% | -52.0% | |
| UPST | New | UPSTART HLDGS INC | $23,357,000 | – | 573,184 | +100.0% | 0.62% | – |
| CTIC | CTI BIOPHARMA CORP | $22,992,000 | +49.8% | 7,140,450 | 0.0% | 0.61% | -6.6% | |
| AVEO | AVEO PHARMACEUTICALS INC | $22,809,000 | -2.9% | 3,952,958 | 0.0% | 0.60% | -39.4% | |
| MEIP | MEI PHARMA INC | $22,527,000 | -15.4% | 8,533,072 | 0.0% | 0.60% | -47.2% | |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $22,323,000 | -4.3% | 6,643,704 | 0.0% | 0.59% | -40.3% | |
| GERN | GERON CORP | $21,404,000 | -8.6% | 13,461,538 | 0.0% | 0.56% | -43.0% | |
| LUMO | LUMOS PHARMA INC | $18,807,000 | +158.4% | 526,663 | 0.0% | 0.50% | +61.4% | |
| CSBR | CHAMPIONS ONCOLOGY INC | $18,491,000 | +16.6% | 1,713,720 | 0.0% | 0.49% | -27.3% | |
| VTGN | New | VISTAGEN THERAPEUTICS INC | $18,158,000 | – | 9,360,000 | +100.0% | 0.48% | – |
| XENE | XENON PHARMACEUTICALS INC | $15,259,000 | +38.9% | 992,107 | 0.0% | 0.40% | -13.3% | |
| IVA | INVENTIVA SAads | $15,104,000 | +22.7% | 1,041,666 | 0.0% | 0.40% | -23.4% | |
| DZSI | DZS INC | $14,793,000 | +65.1% | 956,255 | 0.0% | 0.39% | +3.2% | |
| TRVI | TREVI THERAPEUTICS INC | $14,377,000 | -39.9% | 5,940,796 | 0.0% | 0.38% | -62.5% | |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $10,063,000 | +15.7% | 4,141,308 | 0.0% | 0.27% | -27.7% | |
| SENS | Sell | SENSEONICS HOLDINGS INC | $9,974,000 | +80.7% | 11,464,235 | -19.0% | 0.26% | +12.4% |
| OBSV | OBSEVA SA | $9,540,000 | -16.1% | 4,586,563 | 0.0% | 0.25% | -47.7% | |
| SYBX | SYNLOGIC INC | $9,135,000 | +6.9% | 4,229,410 | 0.0% | 0.24% | -33.4% | |
| RGLS | Buy | REGULUS THERAPEUTICS INC | $8,709,000 | +725.5% | 6,451,056 | +214.3% | 0.23% | +411.1% |
| TRVN | TREVENA INC | $8,157,000 | -28.4% | 3,811,691 | 0.0% | 0.22% | -55.5% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $8,147,000 | +137.5% | 2,382,286 | 0.0% | 0.22% | +48.3% | |
| LQDA | LIQUIDIA TECHNOLOGIES INC | $7,334,000 | -40.0% | 2,486,062 | 0.0% | 0.19% | -62.5% | |
| MRKR | MARKER THERAPEUTICS INC | $7,250,000 | -3.3% | 5,000,000 | 0.0% | 0.19% | -39.9% | |
| ERYP | ERYTECH PHARMA SAadr | $5,769,000 | +53.8% | 625,000 | 0.0% | 0.15% | -4.4% | |
| TCON | TRACON PHARMACEUTICALS INC | $4,057,000 | +126.3% | 346,718 | 0.0% | 0.11% | +40.8% | |
| MLND | MILLENDO THERAPEUTICS INC | $3,781,000 | +31.3% | 1,766,779 | 0.0% | 0.10% | -18.0% | |
| PLTR | Sell | PALANTIR TECHNOLOGIES INCcl a | $1,413,000 | +98.5% | 59,980 | -20.0% | 0.04% | +23.3% |
| AKTX | AKARI THERAPEUTICS PLCadr | $837,000 | +6.4% | 452,167 | 0.0% | 0.02% | -33.3% | |
| SNSS | SUNESIS PHARMACEUTICALS INC | $258,000 | +59.3% | 129,827 | 0.0% | 0.01% | 0.0% | |
| ALTR | Exit | ALTAIR ENGR INC | $0 | – | -11,977 | -100.0% | -0.02% | – |
| DKNG | Exit | DRAFTKINGS INC | $0 | – | -23,902 | -100.0% | -0.06% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -5,959,520 | -100.0% | -4.70% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.